Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Jan;32(1):e22217.
doi: 10.1002/jcla.22217. Epub 2017 Apr 10.

Determination of irinotecan, SN-38 and SN-38 glucuronide using HPLC/MS/MS: Application in a clinical pharmacokinetic and personalized medicine in colorectal cancer patients

Chalirmporn Atasilp  1   2 , Pichai Chansriwong  3 , Ekapob Sirachainan  3 , Thanyanan Reungwetwattana  3 , Apichaya Puangpetch  1   2 , Santirhat Prommas  1   2 , Suwannee Sirilerttrakul  3 , Budsaba Rerkarmnuaychoke  4 , Sansanee Wongwaisayawan  5 , Chonlaphat Sukasem  1   2
Affiliations

Determination of irinotecan, SN-38 and SN-38 glucuronide using HPLC/MS/MS: Application in a clinical pharmacokinetic and personalized medicine in colorectal cancer patients

Chalirmporn Atasilp et al. J Clin Lab Anal. 2018 Jan.

Abstract

Background: Irinotecan (CPT-11) is chemotherapy used mainly in the metastatic colorectal cancer. The purpose of this study was to develop and validate the LC-MS/MS for the simultaneous determination of CPT-11, SN-38, and SN-38G.

Methods: A 100 μL of plasma was prepared after protein precipitation and analyzed on a C18 column using 0.1% acetic acid in water and 0.1% acetic acid in acetonitrile as mobile phases. The mass spectrometer worked with multiple reaction monitoring (MRM) in positive scan mode. The standard curves were linear on a concentration range of 5-10 000 ng/mL for CPT-11, 5-1000 ng/mL for SN-38, and 8-1000 ng/mL for SN-38G.

Results: In this assay, the intra and interday precision consisted of ≤9.11% and ≤11.29% for CPT-11, ≤8.70% and 8.31% for SN-38, and ≤9.90 and 9.64% for SN-38G.

Conclusion: This method was successfully used to quantify CPT-11, SN-38, and SN-38G and applied to a pharmacokinetic study.

Keywords: CPT-11; LC-MS/MS; SN-38; SN-38G; colorectal cancer.

PubMed Disclaimer

Figures

Figure 1
Figure 1
The plasma concentration time curves of CPT‐11, SN‐38, and SN‐38G observed in patients (N=4) receiving 180 mg/m2 of CPT‐11 in 90 minutes
See this image and copyright information in PMC

References

    1. Achenbach CJ, Darin KM, Murphy RL, Katlama C. Atazanavir/ritonavir‐based combination antiretroviral therapy for treatment of HIV‐1 infection in adults. Future Virol. 2011;6:157‐177. - PMC - PubMed
    1. Newton KF, Newman W, Hill J. Review of biomarkers in colorectal cancer. Colorectal Dis. 2012;14:3‐17. - PubMed
    1. Di Paolo A, Bocci G, Polillo M, et al. Pharmacokinetic and pharmacogenetic predictive markers of irinotecan activity and toxicity. Curr Drug Metab. 2011;12:932‐943. - PubMed
    1. Rothenberg ML, Kuhn JG, Burris HA 3rd, et al. Phase I and pharmacokinetic trial of weekly CPT‐11. J Clin Oncol. 1993;11:2194‐2204. - PubMed
    1. Mathijssen RH, van Alphen RJ, Verweij J, et al. Clinical pharmacokinetics and metabolism of irinotecan (CPT‐11). Clin Cancer Res. 2001;7:2182‐2194. - PubMed

MeSH terms